Effectiveness of Two Intracanal Irrigation Solutions
Launched by MISR UNIVERSITY FOR SCIENCE AND TECHNOLOGY · May 18, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective two different liquids used during root canal treatment are in reducing pain after the procedure for men suffering from a specific dental issue called irreversible pulpitis. Irreversible pulpitis is a painful condition where the pulp inside the tooth becomes inflamed and infected, often requiring immediate treatment to relieve pain and save the tooth. The trial aims to see if one of these liquids is better at easing pain after the treatment than the other.
To participate in this study, you must be a man aged between 25 and 50 who has been diagnosed with symptomatic irreversible pulpitis and is experiencing significant pain. You should be in good health according to a standard medical assessment and be willing to provide consent and communicate with the research team for a week after the treatment. This trial has not started recruiting participants yet, but if you fit the criteria, it could be an opportunity to help improve pain management for others in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Case diagnosed as having symptomatic irreversible pulpitis with symptomatic apical periodontitis
- • Patients requiring emergency RCT
- • Pre-operative pain score 7 on Numerical Rating (NRS) scale
- • Middle aged males (25-50)
- • Medical profile ASA1
- • Willing to sign the consent form
- • Willing to answer our call for one week period
- Exclusion Criteria:
- • Females
- • Medical conditions above ASA1
- • Multi-rooted teeth
- • Patients younger or older than (25-50)
About Misr University For Science And Technology
MISR University for Science and Technology is a leading institution dedicated to advancing healthcare and scientific research through innovative clinical trials. With a strong focus on interdisciplinary collaboration, the university leverages its diverse expertise to address pressing medical challenges and enhance patient outcomes. Committed to ethical research practices and regulatory compliance, MISR University fosters a robust environment for clinical investigation, aiming to contribute valuable insights to the global medical community. Through its rigorous methodologies and emphasis on scientific excellence, the university strives to translate research findings into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported